NCT06122311View on ClinicalTrials.gov

Drug Nephrotoxicity Amelioration by N-acetylcysteine

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

June 10, 2024

Study Completion Date

June 10, 2024

Conditions
Drug-Induced Nephropathy
Interventions
DRUG

N Acetylcysteine

N-acetylcysteine sachets 600 mg twice daily

Trial Locations (1)

Unknown

Helwan University, Cairo

All Listed Sponsors
lead

Helwan University

OTHER

NCT06122311 - Drug Nephrotoxicity Amelioration by N-acetylcysteine | Biotech Hunter | Biotech Hunter